Competing interests
L.G. declares contracted research relationships (institutional) with Alyssum Therapeutics, AstraZeneca, Boehringer Ingelheim, Cogent Biosciences, Genentech and Tyra Biosciences; consultancy roles for AbbVie, Agenus, AstraZeneca (on a drug safety monitoring board), BeOne Medicines, Blueprint Medicines, Boehringer Ingelheim, Civela, Compass Therapeutics, Elevar, Exelixis, Guerbet, Jazz Pharmaceuticals, Kinnate Biopharma, Merck, Relay Therapeutics, Revolution Medicines, Servier, Surface Oncology, Taiho, TransThera Biosciences, Tyra Biosciences and Xilio Therapeutics. F.S. declares no competing interests.
